CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)
NCT03559660
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Crohn's Disease
Interventions
DRUG:
Certolizumab Pegol
Sponsor
UCB Biopharma SRL